LUTZ, FL / Accesswire / 08/24/2022 / TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or “the Company”), a healthcare IT company focused on digitizing the retail pharmacy experience in the United States by streamlining drug purchases, prescription visits and patient engagement , announced today declare. That it has ended the proposed public takeover offer announced on August 23, 2022. The termination is a result of the Company’s management’s assessment that current market conditions are not conducive to an offering on terms that are in the best interests of the Company’s shareholders. , As a result of such termination, no common shares will be sold under the offering.
The offering was made pursuant to the “Shelf” registration statement on Form S-3 (File # 333-266432) filed with the Securities and Exchange Commission (SEC) and declared by the SEC effective August 8, 2022 and attached prospectus is included therein. This press release will not solicit an offer to sell or buy any securities described herein, nor will the sale of such securities take place in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of such state or jurisdiction. Before registering or qualifying below.
TRxADE Health, Inc. via
TRxADE HEALTH, Inc. (NASDAQ: MEDS) is a healthcare IT company focused on digitizing the pharmacy retail experience in the United States by streamlining drug purchases, prescription visits and patient engagement. + Members nationwide promoting price transparency and offering patient-centric telehealth and televeteran services under the Bonum Health brand. For more information about TRxADE Health, please visit the Company’s IR website at investors.trxadehealth.com.
This press release may contain forward-looking statements, including information about management’s belief in TRxADE’s future expectations, plans and prospects within the meaning of the federal securities laws, including the Private Securities Acts of 1995. Safe harbor provisions are contained in the Litigation Reform Act. In particular, the words “may be”, “may be”, “expect”, “intend”, “plan”, “seek”, “estimate”, “believe”, “believe”, “believe”, “predict”, ” likely”, “continue”, “likely”, “will”, “will” and variations of these words and similar expressions, or negative or similar expressions of these words are intended to be forward-looking statements. is to be identified. All statements in this press release are forward-looking statements, other than statements of historical fact about an action, event or development. These statements involve known and unknown risks, uncertainties and other factors that could cause the results of TRxADE, its divisions and concepts to differ materially from those expressed or implied by such statements. These risks include risks related to contracts with third parties, including Coborns and Galt Pharmaceuticals; our ability to raise funds in the future if needed and the terms of such funding, including those arising from potential dilution; our ability to proceed as an ongoing concern; Projected profits, expected users and projected revenue of our company with Exchange Health; Amounts due from us that may be payable to Exchange Health in connection with the Agreement with Exchange Health; security interests under some of our credit agreements; The fact that we own Bonum Health, Inc. Examination of strategic options for the subsidiary; Our operations will not become profitable; the economic viability of new businesses, applications, products and technologies and the costs of such items; the Company’s stock repurchase program; accepting the Company’s product offerings; claims relating to alleged infringement of the intellectual property rights of others; our ability to monetize our technology solutions; technical problems with our websites, apps and products; risks related to the execution of our acquisition strategies; pharmaceutical supply chain challenges posed by the COVID-19 pandemic and related matters; our ability to manage our growth; The adverse impact on our operations related to the opioid painkiller health crisis; regulatory and licensing risks; risks related to changes in the US healthcare environment; the status of our information systems, facilities and distribution networks; risks related to the operations of our more established competitors; regulatory changes; new competitors who may have more resources than us; increasing direct consumer sales of medicines; health fraud; COVID-19, government responses to it, economic slowdown and increased inflation and potential slowdown as a result; changes in laws or regulations relating to our business; data protection law; System error; dependence on current management; our development strategy; dilution that may be caused by future offerings; Elevated inflation, elevated interest rates and supply chain issues; and others contained in TRxADE’s filings with the Securities and Exchange Commission from time to time, including but not limited to Forms 10-KS and 10-Q and the “Risk Factors” section on Forms Is. 8 -K’s, which it has filed with the U.S. Securities and Exchange Commission (SEC) and files from time to time, and specifically our Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 and our Annual Report on Form 10-K for the year ended 31 December 2021. These reports are available at www.sec.gov. Other unknown or unanticipated factors could also have a material adverse effect on TRxADE’s future results and/or cause our actual results and financial condition to differ materially from those projected in the forward-looking statements. The forward-looking statements contained in this press release speak only as of this date. TRxADE cannot guarantee future results, activity levels, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We will not release any of these forward-looking statements to reflect changes in actual results, new information or future events, changes in assumptions or other factors affecting us, except as required by applicable law. Take no responsibility for updating. If we update one or more forward-looking statements, there should be no implication that we will make further updates with respect to those or other forward-looking statements.
Source: TRxADE Health, Inc.
Check out the source version on accesswire.com: